UPDATED May 08, 2024
Discover U.S. Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RSVR | US$8.51 | -1.8% | 38.6% | US$555.5m | US$13.00 | PE3022.4x | E229.8% | n/a | Media | ||
YTRA | US$1.47 | 2.8% | -28.6% | US$89.6m | US$4.00 | PS1.7x | E207.1% | n/a | Consumer Services | ||
RVAC | US$11.15 | 11.2% | n/a | US$348.4m | US$14.50 | PE-83x | E198.4% | n/a | Diversified Financials | ||
STRT | US$21.60 | -6.2% | 19.9% | US$87.6m | US$29.00 | PE380.3x | E193.1% | 0% | Automobiles | ||
AVTA | US$25.99 | 0.2% | 6.2% | US$957.1m | US$28.00 | PE4003.1x | E184.1% | n/a | Diversified Financials | ||
MTRX | US$11.84 | 6.3% | 112.9% | US$325.7m | US$17.00 | PB1.8x | E178.7% | n/a | Capital Goods | ||
ASRT | US$1.06 | 14.5% | -86.0% | US$105.6m | US$3.00 | PB0.7x | E176.4% | n/a | Pharmaceuticals & Biotech | ||
RAMP | US$32.26 | -0.09% | 32.4% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | Software | ||
LTRX | US$3.74 | 1.2% | -4.0% | US$138.7m | US$7.60 | PB1.8x | E174.9% | n/a | Tech | ||
ISPR | US$5.99 | 10.5% | -34.9% | US$330.7m | US$11.00 | PS2.4x | E170.2% | n/a | Food, Beverage & Tobacco | ||
ARI | US$9.97 | -0.3% | 6.3% | US$1.4b | US$10.00 | PS10.5x | E169.8% | 14.0% | Diversified Financials | ||
HTLD | US$11.20 | 7.7% | -25.9% | US$864.8m | US$12.20 | PB1x | E166.8% | 0.7% | Transportation | ||
SNCR | US$9.00 | 39.5% | 16.3% | US$67.5m | US$19.68 | PB3.7x | E165.6% | n/a | Software | ||
DTC | US$1.97 | 6.5% | -71.5% | US$177.8m | US$3.99 | PB0.5x | E165.2% | n/a | Consumer Durables | ||
PBI | US$5.20 | 23.5% | 66.7% | US$935.5m | US$5.00 | PE-2.4x | E163.4% | 3.8% | Commercial Services | ||
AJX | US$3.59 | -1.6% | -35.2% | US$132.0m | US$6.00 | PB0.5x | E162.0% | 11.1% | Diversified Financials | ||
GORV | US$3.99 | 6.1% | -62.5% | US$53.6m | US$8.25 | PB0.4x | E161.4% | n/a | Retail | ||
RMAX | US$8.00 | 11.1% | -57.7% | US$253.5m | US$9.00 | PB0.4x | E161.3% | 0% | Real Estate Management and Development | ||
THRY | US$21.45 | -9.4% | 2.0% | US$769.6m | US$29.50 | PB4.6x | E160.3% | n/a | Media | ||
SRT | US$4.42 | 0.2% | 11.6% | US$178.3m | n/a | PB1x | E160.3% | n/a | Commercial Services | ||
CCEL | US$8.74 | 5.4% | 85.2% | US$69.9m | US$9.00 | PS2.3x | E159.8% | n/a | Healthcare | ||
MMI | US$33.34 | 5.9% | 18.7% | US$1.3b | US$20.00 | PS2.1x | E159.7% | 1.5% | Real Estate Management and Development | ||
EXPI | US$11.85 | 16.7% | -11.4% | US$1.9b | US$11.58 | PB8.2x | E159.4% | 1.7% | Real Estate Management and Development | ||
OIS | US$4.42 | 9.7% | -36.5% | US$289.6m | US$7.40 | PB0.4x | E159.1% | n/a | Energy |